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Immunoreactiveendothelin-I (ET-l) and big-endothelin-I (big-ET-l) were detected in conditioned medium ofcultured rat pleural mesathelial cells 
by using sensitive sandwich-type nzyme immunoassays, The amounl of both ET-I and big-ET-1 increased time-dependently. In both instances. 
maximal amount was detectable ~II conditioned medium obtained after 72 h in culture (ET-l: 117.1 2 30. I p&lo6 cells; big-ET-l: 2.4 2 2.1 ps/IO’ 
G&S>. Fe&z> ~Userunt m&z& slr;ttulated Ihe qmduc&t of lmlt ET-1 and big-ET-l. 
Endothelin: Big-endothelin; Mesothclial cell; Pleura; Rat 
1. INTRODUCTION 
Eiiabtliclih- I’ (‘Er? 1’j was orlginailjr l’sol&ed t”rom trie 
conditioned medium of cultured porcine aortic endothe- 
lial cells as a potent vasoconstrictor peptide with 21 
amino acid residues [l]. Cloning and sequencing of 
prepro-ET-l cDNA have revealed the identity of 
human and porc\ne ET-Is I1,21, These studies have also 
suggested the involvement of a precursor pepticfe, ‘big 
endoehelin- 1 (big-ET-l )‘, in the biosynthetic pathway of 
ET-l. The conversion from big-ET-l to ET-L was essen- 
tial for full physiological activity. Recent studies have 
documented that besides aortic endothelium, other 
types of cells such as airway epithelial cells [3], me- 
sangial cells [4], spinal cord [S], and epithelial-like turner 
cells [6] may also generate ET. 
ETA) for ET-1 and big-ET-1 [6,71. Our findings indi- 
cated fhat cultured mesdhdid ~51s ,nroduc& II&I im- 
munoreactiLe ET i and’ ti&E~ I’. 
2. MATERIALS AND METHODS 
Mesothelial cells which also have epithelial-like char- 
acters are a biological barrier between an organ and the 
external ‘envelope’ and may have functions of trans- 
port, equilibrium maintenance, and protection. From a 
biological point of vieuw, therefore, it could be interest- 
ing to know more about the metabolism and physiology 
of these cells. Although there is no observation concern- 
ing ET production on mesothelial cells, it is conceivable 
that mesothelial cells may also generate ET. The present 
study was designed to test this possibility. For this 
purpose, mesothelial cells were maintained in vitro and 
their conditioned medium was evaluated using a sensi- 
tive sandwich-type enzyme immunoassay (sandwich- 
Rat pleural mesolhelial cells were routinely maintained in complete 
CUkUfC 17IebiU~, W&h 12VLlSkisrS Qf &tbXCQ’s &niKd esSerrtti 
medium (DMEM; Gibco) with 10% fetal calf serum (FCS; Gibco), 10’ 
Wl ~nicillin. and 100 ms/l srreptomycin, at 3?C in humidified en- 
vironment containing 5% CO, as previously described [8]. Eight to IO 
passage number of cells were used in lhis experiment. When con- 
fluence was reached (55 cm’), the cells were washed Lhree times with 
Hanks’ balanced salt solution (HBSS)and incubated wilheither IO ml 
of serum-free medium or medium containing 10% FCS for up to 72 
h. Conditioned medium was collected at defmed culture time, and 
frozen in aliquots at -7OOC. After collecting conditioned medium, 
viable cell numbers were confirmed by Trypon blue dye exclusion. 
2.2. Sandwich-&IA 
The amount of immunoreactive ET-I and big-ET-1 in the condi- 
tioned medium was determined by sandwich-EIA melhods as de- 
scribed previously [6,7]. Briefly. AwETN4Ocoated microtesl plates 
were incubated at 4°C for 24 h with 100 fiuVwcll of standard ET-l. 
human big-ET-l. or the sample to be tested in buffer E (0.02 M 
phosphate bufler, pH 7.0, containing 10% Block Ace. 2 mg/ml of 
bovine serum albumin WA), 0.4 M NaCI. and 2 mM EDTA). After 
being washed with PBS, the plates were subjected 10 the reaction with 
100 ~mlwcll of HRP-labeled anti-ET-l (IS-2l)Fab’ or HRP-labeled 
anti-human big-ET-1 (22-3S)Fab’ in buffer C (0.02 M phosphate 
buffer, pH 7.0. containing 10 mg/ml of BSA, 0,4 M NaCI, and 2 mM 
EDTA) for 24 h at 4’C. The plates were washed with PBS. and the 
bound enzyme activity was measured using a TMB microwell pe- 
roxidasc system (KPL Inc., Gaitbcrsbuq, USA). 
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(Waters ksociaks. Milford, MA) as previously described [7]. The 
adsorbed material was cluted with 5 ml of Acetic acid/ethsnol~H~O 
(4:86:lO) and concentrated. The concentraled sample was separated 
on a TSK ODS-80 (4,6 x 250 mm; Tosoh, Co. Ltd., Japan) column. 
The solvents used were: (A) 5% CH$N containing 0.05% TFA; and 
(B) 60% CH,CN containing 0.05% TFA. In the elution, the B con- 
centration was lincary elevated O-406 over 5 min. 40-6546 over 20 
min. and then 65-1006 over 5 min at a flow rate of I .O ml/mim [6], 
Each fraction (0.5 ml) was lyophilired, reconstituted with the ElA 
buffer. and subjected lo the EIAs for ET-I and big-ET-l. 
3. RESULTS AND DISCUSSION 
We have detected immunoreactive ET- 1 and big-ET- 
1 in conditioned medium from cultured rat pleural me- 
sothelial cells whose viability, based on Trypan blue dye 
exclusion, always exceeded 95% (Fig. 1). These meso- 
thelial cells, produced more immunoreactive ET-1 than 
big-ET- 1. The production of immunoreactive ET-1 was 
progressively increased in culture time-dependent 
manner. The amount of immunoreactive big-ET-1 was 
slightly increased with culture time. In both instances, 
maximal amount was detectable in conditioned medium 
obtained after 72 h in culture (immunoreactive ET-l: 
117.1 f 30.1 pg/lO” cells; immunoreactive big-ET-l: 2.4 
f 2.1 pg/106 cells). In addition, we examined the effects 
of FCS on the production of immunoreactive ET-1 and 
big-ET-1 in the conditioned medium. As shown in Fig. 
2, FCS markedly stimulated the production of both 
immunoreactive ET-1 and big-ET-l. Because levels of 
immunoreactive ET-1 and big-ET-1 in control medium 
both serum-free and containing FCS were below the 
limits of detection, immunoreactive ET-1 and big-ET-1 
detected in conditioned medium were not components 
of FCS. Immunoreactive ET-l and big-ET-1 were also 
characterized by reverse-phase HPLC (Fig. 3). Immu- 
noreactive ET-1 and big-ET-1 appeared at the eiution 
positions corresponding to synthetic ET-I and human 
big-ET-l, respectively. These findings indicated that 
a4 48 
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Fig. I. Time course illustrating the progressive production of immu- 
norcactive ET-I and big-ET-1 in conditioned medium obtained from 
rat pleural mesothelial cell cullurrs. Open circles = immunoreactive 
ET-I; solid circles = immunoreactive big-ET-l, Mean + SE of 3 ex- 
periments for each category. 
cultured mesothelial cells generated both immunoreac- 
tive ET- 1 and big-ET-l, 
To our knowledge, mesothelial cells have not been 
shown previously to elaborate both ET and big-ET. 
Giaid and associales [9] recently have shown that 
pulmonary endocrine cells of developing human lung 
mainly expressed ET-like immunoreactivity. Radio- 
immunoassay has revealed the presence of high 
concentration of ET immunoreactivity in the porcine 
and rat lung [ 10,111. Moreover, ET receptor binding 
sites have been detected in the cardiovascular and respi- 
ratory systems of mammals [12-141. In these studies, 
however, there was no investigation for ET about meso- 
thelial cell layer in respiratory tract. 
It seems that mesothelial cells may also respond to 
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Fig. 2. Effects of FCS on the production of immunoreactive ET-I (A) 
and big-ET-1 (8) in conditioned medium obtained from rat pleural 
mesothelial cell cultures. Mean L SE of 3 experiments for each ca- 
tegory. Solid bars = pleural mesothelial cells cultured without FCS; 
open bars = pleural mesothelial cells cultured with FCS. 
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Fig. 3. Reverse-phase HPLC of the culture conditioned medium of rat pleural mesothelial cells on a TSK GDS-SOTM column. Aliquots of the 
fractions were subjected to sandwich-EIAs for ET-1 (A) and big-ET-1 (IQ. Arrows indicate the elution positions of synthetic ET-I and human 
big-ET- I, 
serum factors such as transforming growth factor-b and 
thrombin which induce preproET-1 gene expression in 
endothelial, cpithelial, and mesangial cells [4,1 S-1 81, be- 
cause production of ET in mesothelial cells was en- 
hanced by the addition of FCS. Moreover, ET acts as 
a potent mitogen in fibroblasts [19-211. The growing 
v:er:,, therefore, is that the abi!ity of mesothe!ia! ce!!s to 
produce ET may play a role in the reparative response 
of injury to provide a signal for fibroblast proliferation 
in submesothelial layer. Further ET may have the func- 
tion of regulating the transport and equilibrium main- 
tenance in the serous surfaces. 
In summary, we have shown that cultured rat pleural 
mesothelial cells can generate immunoreactive ET-l 
and big-ET-l. Although further study will be necessary 
to determine the physiological and pathophysiological 
role of ET peptides in the serous surfaces. mesothelial 
cells may play an important role in these regions. 
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